首页> 外文OA文献 >Efficacies of Quinupristin-Dalfopristin Combined with Vancomycin In Vitro and in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus in Relation to Cross-Resistance to Macrolides, Lincosamides, and Streptogramin B- Type Antibiotics
【2h】

Efficacies of Quinupristin-Dalfopristin Combined with Vancomycin In Vitro and in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus in Relation to Cross-Resistance to Macrolides, Lincosamides, and Streptogramin B- Type Antibiotics

机译:奎奴普林汀-达福普汀联合万古霉素的体外疗效以及与耐大环内酯类,林可酰胺类和链霉菌素B型抗生素交叉耐药有关的实验性心内膜炎对因耐甲氧西林金黄色葡萄球菌所致

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A beneficial effect of the combination of quinupristin-dalfopristin and vancomycin was observed against two methicillin-resistant strains of Staphylococcus aureus harboring or not harboring the ermC gene, which codes for constitutive macrolide, lincosamide, and streptogramin B resistance. The beneficial effect was observed in time-kill studies, in which the drugs were used at inhibitory concentrations, and in a rabbit model of endocarditis, in which the combination was highly bactericidal and more active than monotherapies.
机译:观察到奎奴普汀-达福普汀和万古霉素的组合对两种带有或不带有ermC基因的金黄色葡萄球菌耐药菌株均具有有益作用,该菌株编码组成型大环内酯,林可酰胺和链霉菌素B耐药性。在以抑制浓度使用药物的时间杀灭研究中,以及在心内膜炎的兔子模型中观察到了有益效果,在该模型中,这种组合具有很高的杀菌作用,并且比单一疗法更具活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号